HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: findings of the PERSPECTIVES study.

AuthorsUsha Chakravarthy, Giovanni Staurenghi, Kenneth Kwok, Charles S Tressler, Ronald Buggage, PERSPECTIVES Study Group
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 96 Issue 10 Pg. 1351-4 (Oct 2012) ISSN: 1468-2079 [Electronic] England
PMID22872673 (Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Aptamers, Nucleotide
  • pegaptanib
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Aptamers, Nucleotide (therapeutic use)
  • Choroidal Neovascularization (complications, diagnosis, drug therapy)
  • Early Diagnosis
  • Humans
  • Macular Degeneration (complications)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: